Oracle (NYSE:ORCL) Stock Falls 1.6% - Time to Sell?

Key Points

• Oracle shares fell 1.6% to $129.10, trading below both their 50-day ($144.66) and 200-day ($158.56) moving averages amid investor concerns about AI spending and execution.
• Oracle continues expanding its AI and cloud offerings through new Fusion applications, an AstraZeneca healthcare partnership, and ongoing customer adoption; its reported cloud backlog exceeds $664 billion.
• Financial risks remain significant: AI data-center expansion is driving deeply negative free cash flow, higher leverage, and cash-burn concerns, while reports of project delays and vendor-supported financing add execution and balance-sheet risk. Analysts nevertheless maintain a “Moderate Buy” consensus with an average target of $249.52.

Oracle Corporation (NYSE:ORCL - Get Free Report) dropped 1.6% on Wednesday. The company traded as low as $127.70 and last traded at $129.10. 26,006,668 shares traded hands during mid-day trading, a decline of 12% from the average session volume of 29,427,369 shares. The stock had previously closed at $131.14.

Key Oracle News

Here are the key news stories impacting Oracle this week:

• Positive Sentiment: Oracle introduced new Fusion Claw agentic applications for human resources and an AI Agent Studio for industry-specific workflows. The products expand Oracle’s AI offering and could support additional cloud application demand. Oracle Introduces Claw-Powered Fusion Agentic Applications for HR
• Positive Sentiment: AstraZeneca and Oracle agreed to explore AI and real-world data tools for clinical-trial recruitment, evidence generation, and healthcare workflows. The partnership supports Oracle’s effort to diversify its AI opportunity beyond data-center infrastructure. Oracle and AstraZeneca Partner to Advance AI-enabled Healthcare Innovation
• Positive Sentiment: Southwest General is expanding its use of Oracle Health and Fusion Cloud products, providing evidence of continued customer adoption across healthcare, finance, and operations. Southwest General Expands Relationship with Oracle
• Positive Sentiment: AI-cloud sentiment improved after Elon Musk dismissed overcapacity concerns, helping specialized providers recover and offering a modestly supportive backdrop for Oracle’s infrastructure business. AI Cloud Stocks Rise as Musk Calls Overcapacity Talk Ridiculous
• Neutral Sentiment: Oracle’s cloud backlog reportedly exceeds $664 billion, highlighting substantial future demand. However, investors are focused on whether that backlog can translate into cash flow and sustainable returns.
• Neutral Sentiment: Some analysts see the recent sell-off as a long-term buying opportunity, while comparisons with Microsoft emphasize Oracle’s faster cloud growth but heavier debt burden and weaker free-cash-flow profile. Oracle Stock Is Falling as AI Spending Worries Mount
• Negative Sentiment: Oracle’s free cash flow remains deeply negative as it funds its AI data-center buildout, and management has not provided a clear timeline for a recovery. The mismatch between rapid growth and an elevated valuation is weakening investor confidence. Oracle’s Growth to Valuation Mismatch Is Less and Less Compelling
• Negative Sentiment: TD Cowen suggested Nvidia may be helping finance Oracle’s data-center expansion, but the report also highlights Oracle’s cash burn, leverage, and credit rating only one notch above junk. Possible reliance on vendor-supported financing increases balance-sheet concerns. TD Cowen Thinks Nvidia Is Helping Oracle Get Its Data Centers Financed
• Negative Sentiment: Reports that Oracle has invoked force majeure related to its New Mexico data-center project have raised questions about construction execution and whether planned AI capacity can be delivered on schedule. Oracle Calls Force Majeure Already?

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on ORCL shares. UBS Group lifted their price target on Oracle from $245.00 to $250.00 and gave the company a "buy" rating in a research report on Friday, September 11th. Rothschild & Co Redburn decreased their price objective on shares of Oracle from $155.00 to $110.00 and set a "sell" rating on the stock in a research report on Monday, July 20th. Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $284.00 target price (up from $229.00) on shares of Oracle in a research note on Friday, September 11th. Sanford C. Bernstein reissued a "buy" rating on shares of Oracle in a research note on Friday, September 25th. Finally, DZ Bank reissued a "buy" rating on shares of Oracle in a report on Thursday, September 17th. One analyst has rated the stock with a Strong Buy rating, thirty-five have assigned a Buy rating, nine have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Oracle currently has an average rating of "Moderate Buy" and an average target price of $249.52.

Oracle Trading Down 1.6%

The stock has a fifty day moving average of $144.66 and a two-hundred day moving average of $158.56. The company has a market capitalization of $390.36 billion, a PE ratio of 20.24, a PEG ratio of 0.91 and a beta of 1.78. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 1.89.

Oracle (NYSE:ORCL - Get Free Report) last issued its quarterly earnings results on Thursday, September 10th. The enterprise software provider reported $1.92 EPS for the quarter, beating analysts' consensus estimates of $1.74 by $0.18. The business had revenue of $19.34 billion for the quarter, compared to analysts' expectations of $19.13 billion. Oracle had a net margin of 26.36% and a return on equity of 48.85%. The business's quarterly revenue was up 29.6% on a year-over-year basis. During the same period last year, the business earned $1.47 earnings per share. Oracle has set its Q2 2027 guidance at 1.850-1.930 EPS and its FY 2027 guidance at 8.100-8.100 EPS. As a group, sell-side analysts anticipate that Oracle Corporation will post 6.73 earnings per share for the current fiscal year.

Oracle Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 23rd. Shareholders of record on Friday, October 9th will be paid a $0.50 dividend. The ex-dividend date of this dividend is Friday, October 9th. This represents a $2.00 annualized dividend and a yield of 1.5%. Oracle's payout ratio is currently 31.35%.

Insider Buying and Selling at Oracle

In other news, EVP Maria Smith sold 2,631 shares of the firm's stock in a transaction dated Tuesday, September 22nd. The stock was sold at an average price of $151.70, for a total transaction of $399,122.70. Following the transaction, the executive vice president directly owned 64,357 shares of the company's stock, valued at approximately $9,762,956.90. This trade represents a 3.93% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Michael Sicilia sold 22,562 shares of Oracle stock in a transaction dated Tuesday, September 22nd. The stock was sold at an average price of $151.59, for a total value of $3,420,173.58. Following the completion of the transaction, the chief executive officer owned 182,929 shares in the company, valued at approximately $27,730,207.11. This represents a 10.98% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 36,075 shares of company stock worth $5,342,123 over the last three months. Company insiders own 38.40% of the company's stock.

Institutional Trading of Oracle

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in Oracle by 0.8% during the 2nd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 14,680,278 shares of the enterprise software provider's stock valued at $2,151,395,000 after purchasing an additional 123,294 shares during the last quarter. Bank of New York Mellon Corp increased its stake in shares of Oracle by 3.0% during the first quarter. Bank of New York Mellon Corp now owns 13,251,059 shares of the enterprise software provider's stock valued at $1,949,363,000 after buying an additional 384,984 shares during the period. Amundi increased its stake in shares of Oracle by 1.5% during the second quarter. Amundi now owns 9,878,184 shares of the enterprise software provider's stock valued at $1,447,648,000 after buying an additional 144,087 shares during the period. Dimensional Fund Advisors LP raised its holdings in shares of Oracle by 1.7% during the first quarter. Dimensional Fund Advisors LP now owns 8,586,492 shares of the enterprise software provider's stock valued at $1,262,827,000 after acquiring an additional 147,048 shares in the last quarter. Finally, First Eagle Investment Management LLC raised its holdings in shares of Oracle by 1.0% during the second quarter. First Eagle Investment Management LLC now owns 8,516,878 shares of the enterprise software provider's stock valued at $1,248,148,000 after acquiring an additional 81,700 shares in the last quarter. Institutional investors own 42.44% of the company's stock.

About Oracle

Oracle Corporation NYSE: ORCL is a global technology company that develops enterprise software, cloud infrastructure and database technologies. Its products help organizations store, manage, analyze and secure data, while supporting business operations across industries and geographies.

The company's offerings include Oracle Database, Java, Oracle Cloud Infrastructure and a broad portfolio of cloud-based applications. These applications serve functions such as enterprise resource planning, financial management, human resources, supply-chain management, customer experience and industry-specific operations.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.